{"id":127200,"date":"2021-02-26T19:18:23","date_gmt":"2021-02-26T22:18:23","guid":{"rendered":"https:\/\/www.suno.com.br\/noticias\/?p=127200"},"modified":"2021-02-26T19:50:22","modified_gmt":"2021-02-26T22:50:22","slug":"hypera-pharma-hype3-tem-lucro-de-r-3149-mi-no-4t20","status":"publish","type":"post","link":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-tem-lucro-de-r-3149-mi-no-4t20\/","title":{"rendered":"Hypera Pharma (HYPE3) tem lucro de R$ 314,9 mi no 4T20"},"content":{"rendered":"<p>A <a href=\"https:\/\/www.suno.com.br\/acoes\/hype3\/\"><strong>Hypera<\/strong> Pharma (HYPE3)<\/a> apresentou na noite desta sexta-feira (26) seus \u00faltimos resultados trimestrais de 2020, com a empresa apurando um lucro l\u00edquido de R$ 314,9 milh\u00f5es entre os meses de outubro e dezembro, um crescimento de 31,9% ante aos R$ 238,8 milh\u00f5es obtidos no ano anterior.<\/p>\t<div class=\"wrapper-featured-image\">\n\t\t<figure class=\"spotlightImg\">\n\n\t\t\t<picture>\n\t\t\t\t<source media=\"(max-width: 768px)\" srcset=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/02\/74816746-definido-fator-de-reajuste-de-precos-de-medicamentos-para-2021-3.29-400x200.webp\">\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" class=\"newsContent__article__imgCapa lazyloadDisabled \" src=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/02\/74816746-definido-fator-de-reajuste-de-precos-de-medicamentos-para-2021-3.29-800x450.webp\" width=\"800\" height=\"450\" alt=\"Hypera Pharma (HYPE3) tem lucro de R$ 314,9 mi no 4T20\" fetchpriority=high \/>\n\t\t\t<\/picture>\n\n\t\t\t<figcaption class=\"wp-caption-text wp-caption-text--show\">A Hypera Pharma divulgou seus resultados do 4\u00ba trimestre de 2020 nesta sexta-feira<\/figcaption>\n\t\t<\/figure>\n\t<\/div>\n\n\n\t<p>\n\t\t<a href=\"https:\/\/lp.suno.com.br\/planilha-controle-gastos\/\" target=\"_blank\" data-element=\"shortcode-suno-banner\" title=\"Banner SUNO, clique e saiba mais\">\n\t\t\t<picture>\n\t\t\t\t<source media=\"(max-width: 500px)\" srcset=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/400x300-Planilha-controle-de-gastos.png\">\n\t\t\t\t<img class=\"newsContent__article__imgCapa newsContent__article__imgCapa--banner\"\n\t\t\t\t\tsrc=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/1420x240-Planilha-controle-de-gastos.png\"\n\t\t\t\t\tdata-promo-id=\"101751\"\t\t\t\t\t\t\t\t\t\twidth='1420' height='240'\t\t\t\t\talt=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/1420x240-Planilha-controle-de-gastos.png\"\n\t\t\t\t>\n\t\t\t<\/picture>\n\t\t<\/a>\n\t<\/p>\n\n\n<p>O <a href=\"https:\/\/www.suno.com.br\/artigos\/ebitda\/\">Ebitda (lucro antes de juros, impostos, deprecia\u00e7\u00e3o e amortiza\u00e7\u00e3o)<\/a> da Hypera tamb\u00e9m avan\u00e7ou, 55,7%, atingindo R$ 349 milh\u00f5es, contra R$ 224,2 milh\u00f5es registrados no quarto trimestre de 2019.<\/p>\n<p><a href=\"https:\/\/lp.suno.com.br\/suno-one\/\">Suno One: acesse gratuitamente eBooks, Minicursos, Artigos e Video Aulas sobre investimentos com um \u00fanico cadastro. Clique para saber mais!<\/a><\/p>\n<p>No quarto trimestre de 2020, a companhia registrou uma expans\u00e3o recorde do <em>sell-out<\/em> (que considera o pre\u00e7o m\u00e9dio de compra pelas farm\u00e1cias e redes), de 14,6%, a mais alta j\u00e1 apurada pela Hypera em um trimestre desde que passou a concentrar suas opera\u00e7\u00f5es exclusivamente no mercado farmac\u00eautico.<\/p>\n<p>Com isso, a <a href=\"https:\/\/www.suno.com.br\/artigos\/o-que-receita-liquida\/\">receita l\u00edquida<\/a> chegou a R$ 1,134 bilh\u00e3o no trimestre, ou 22,2% superior ao mesmo per\u00edodo de 2019. A carteira de ativos da fam\u00edlia Buscopan, adquirida no terceiro trimestre do ano passado, adicionou R$ 85,7 milh\u00f5es \u00e0 receita.<\/p>\n<p>A Hypera passou de uma posi\u00e7\u00e3o de caixa l\u00edquido, em 2019, para uma posi\u00e7\u00e3o de d\u00edvida, em 2020. A empresa fechou dezembro com uma d\u00edvida l\u00edquida de R$764,1 milh\u00f5es, ou R$1,435 bilh\u00f5es quando considerado o pagamento dos juros sobre capital pr\u00f3prio (JCP) realizado em janeiro de 2021.<\/p>\n<p>A companhia atribuiu o movimento \u00e0 aquisi\u00e7\u00e3o da fam\u00edlia Buscopan e Buscofem e aos investimentos adicionais para expans\u00e3o da capacidade fabril em An\u00e1polis realizados ao longo do ano.<\/p>\n<h2>Hypera aprova programa de recompra<\/h2>\n<p>Ainda nesta sexta-feira, o conselho de administra\u00e7\u00e3o da Hypera aprovou um programa de recompra de a\u00e7\u00f5es ordin\u00e1rias, sem redu\u00e7\u00e3o do capital social.<\/p>\n<p>O prazo m\u00e1ximo para a realiza\u00e7\u00e3o das recompras \u00e9 de at\u00e9 18 meses, com in\u00edcio hoje e t\u00e9rmino em 26 de agosto de 2022.<\/p>\n<p>O total de a\u00e7\u00f5es a serem adquiridas \u00e9 de at\u00e9 4,2 milh\u00f5es a\u00e7\u00f5es ordin\u00e1rias, que representam at\u00e9 1,042% do total de 402.912.657 a\u00e7\u00f5es de emiss\u00e3o da companhia.<\/p>\n<h2>\u00daltima cota\u00e7\u00e3o<\/h2>\n<p>Os pap\u00e9is ordin\u00e1rios da <strong>Hypera<\/strong> fecharam o preg\u00e3o desta sexta-feira em queda de 1,68%, a R$ 32,78. O Ibovespa, \u00edndice de refer\u00eancia da <a href=\"https:\/\/www.suno.com.br\/artigos\/b3\/\">Bolsa de Valores de S\u00e3o Paulo (B3)<\/a> recuou 1,98%, a 110.035,17 pontos.<\/p>\n<p><em>(Mais informa\u00e7\u00f5es em instantes)<\/em><\/p>\n\t<p>\n\t\t<a href=\"https:\/\/lp.suno.com.br\/planilha-de-controle-de-investimentos\/\" target=\"_blank\" data-element=\"shortcode-suno-banner\" title=\"Banner SUNO, clique e saiba mais\">\n\t\t\t<picture>\n\t\t\t\t<source media=\"(max-width: 500px)\" srcset=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/400x300-Controle-de-Investimentos.png\">\n\t\t\t\t<img class=\"newsContent__article__imgCapa newsContent__article__imgCapa--banner\"\n\t\t\t\t\tsrc=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/1420x240-Controle-de-Investimentos.png\"\n\t\t\t\t\tdata-promo-id=\"75934\"\t\t\t\t\t\t\t\t\t\twidth='1420' height='240'\t\t\t\t\talt=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/1420x240-Controle-de-Investimentos.png\"\n\t\t\t\t>\n\t\t\t<\/picture>\n\t\t<\/a>\n\t<\/p>\n\n\n","protected":false},"excerpt":{"rendered":"<p>A Hypera Pharma (HYPE3) apresentou na noite desta sexta-feira (26) seus \u00faltimos resultados trimestrais de 2020, com a empresa apurando um lucro l\u00edquido de R$ 314,9 milh\u00f5es entre os meses de outubro e dezembro, um crescimento de 31,9% ante aos R$ 238,8 milh\u00f5es obtidos no ano anterior. A Hypera Pharma divulgou seus resultados do 4\u00ba [&hellip;]<\/p>\n","protected":false},"author":35,"featured_media":127205,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[64],"tags":[1029,501],"suno_strategy":[],"class_list":["post-127200","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-negocios","tag-balancos-trimestrais","tag-hypera-pharma-hype3"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Hypera Pharma (HYPE3) tem lucro de R$ 314,9 mi no 4T20<\/title>\n<meta name=\"description\" content=\"A Hypera Pharma (HYPE3) apresentou um lucro l\u00edquido de R$ 314,9 milh\u00f5es, crescimento de 31,9%. Clique para saber mais\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-tem-lucro-de-r-3149-mi-no-4t20\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hypera Pharma (HYPE3) tem lucro de R$ 314,9 mi no 4T20\" \/>\n<meta property=\"og:description\" content=\"A Hypera Pharma (HYPE3) apresentou um lucro l\u00edquido de R$ 314,9 milh\u00f5es, crescimento de 31,9%. Clique para saber mais\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-tem-lucro-de-r-3149-mi-no-4t20\/\" \/>\n<meta property=\"og:site_name\" content=\"Suno Not\u00edcias\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/sunoresearch\" \/>\n<meta property=\"og:image\" content=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/02\/74816746-definido-fator-de-reajuste-de-precos-de-medicamentos-para-2021-3.29.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"960\" \/>\n\t<meta property=\"og:image:height\" content=\"636\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Arthur Guimar\u00e3es\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@sunoresearch\" \/>\n<meta name=\"twitter:site\" content=\"@sunoresearch\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Arthur Guimar\u00e3es\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-tem-lucro-de-r-3149-mi-no-4t20\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-tem-lucro-de-r-3149-mi-no-4t20\/\"},\"author\":{\"name\":\"Arthur Guimar\u00e3es\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/053a750a709a263919a20f976caae91c\"},\"headline\":\"Hypera Pharma (HYPE3) tem lucro de R$ 314,9 mi no 4T20\",\"datePublished\":\"2021-02-26T22:18:23+00:00\",\"dateModified\":\"2021-02-26T22:50:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-tem-lucro-de-r-3149-mi-no-4t20\/\"},\"wordCount\":415,\"publisher\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-tem-lucro-de-r-3149-mi-no-4t20\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/02\/74816746-definido-fator-de-reajuste-de-precos-de-medicamentos-para-2021-3.29-jpg.webp\",\"keywords\":[\"balan\u00e7os trimestrais\",\"Hypera Pharma (HYPE3)\"],\"articleSection\":[\"Neg\u00f3cios\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-tem-lucro-de-r-3149-mi-no-4t20\/\",\"url\":\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-tem-lucro-de-r-3149-mi-no-4t20\/\",\"name\":\"Hypera Pharma (HYPE3) tem lucro de R$ 314,9 mi no 4T20\",\"isPartOf\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-tem-lucro-de-r-3149-mi-no-4t20\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-tem-lucro-de-r-3149-mi-no-4t20\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/02\/74816746-definido-fator-de-reajuste-de-precos-de-medicamentos-para-2021-3.29-jpg.webp\",\"datePublished\":\"2021-02-26T22:18:23+00:00\",\"dateModified\":\"2021-02-26T22:50:22+00:00\",\"description\":\"A Hypera Pharma (HYPE3) apresentou um lucro l\u00edquido de R$ 314,9 milh\u00f5es, crescimento de 31,9%. Clique para saber mais\",\"breadcrumb\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-tem-lucro-de-r-3149-mi-no-4t20\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-tem-lucro-de-r-3149-mi-no-4t20\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-tem-lucro-de-r-3149-mi-no-4t20\/#primaryimage\",\"url\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/02\/74816746-definido-fator-de-reajuste-de-precos-de-medicamentos-para-2021-3.29-jpg.webp\",\"contentUrl\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/02\/74816746-definido-fator-de-reajuste-de-precos-de-medicamentos-para-2021-3.29-jpg.webp\",\"width\":960,\"height\":636,\"caption\":\"A Hypera Pharma divulgou seus resultados do 4\u00ba trimestre de 2020 nesta sexta-feira\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-tem-lucro-de-r-3149-mi-no-4t20\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Not\u00edcias\",\"item\":\"https:\/\/www.suno.com.br\/noticias\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neg\u00f3cios\",\"item\":\"https:\/\/www.suno.com.br\/noticias\/negocios\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Hypera Pharma (HYPE3) tem lucro de R$ 314,9 mi no 4T20\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#website\",\"url\":\"https:\/\/www.suno.com.br\/noticias\/\",\"name\":\"Suno Not\u00edcias\",\"description\":\"Seu portal de informa\u00e7\u00e3o sobre o mundo dos investimentos\",\"publisher\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.suno.com.br\/noticias\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#organization\",\"name\":\"Suno Not\u00edcias\",\"url\":\"https:\/\/www.suno.com.br\/noticias\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/09\/suno-logo.png\",\"contentUrl\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/09\/suno-logo.png\",\"width\":180,\"height\":180,\"caption\":\"Suno Not\u00edcias\"},\"image\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/facebook.com\/sunoresearch\",\"https:\/\/x.com\/sunoresearch\",\"https:\/\/www.instagram.com\/suno\",\"https:\/\/www.linkedin.com\/company\/suno-research\/\",\"https:\/\/www.youtube.com\/c\/sunoresearch\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/053a750a709a263919a20f976caae91c\",\"name\":\"Arthur Guimar\u00e3es\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1affd86a11209ae09eb6dd3bcad3e96c?s=96&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1affd86a11209ae09eb6dd3bcad3e96c?s=96&r=g\",\"caption\":\"Arthur Guimar\u00e3es\"},\"description\":\"Arthur Guimar\u00e3es escreve sobre pol\u00edtica, economia e neg\u00f3cios para o portal de not\u00edcias da Suno Research. Atualmente, \u00e9 estudante de jornalismo pela Faculdade C\u00e1sper L\u00edbero.\",\"url\":\"https:\/\/www.suno.com.br\/noticias\/author\/arthur-guimaraes\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Hypera Pharma (HYPE3) tem lucro de R$ 314,9 mi no 4T20","description":"A Hypera Pharma (HYPE3) apresentou um lucro l\u00edquido de R$ 314,9 milh\u00f5es, crescimento de 31,9%. Clique para saber mais","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-tem-lucro-de-r-3149-mi-no-4t20\/","og_locale":"pt_BR","og_type":"article","og_title":"Hypera Pharma (HYPE3) tem lucro de R$ 314,9 mi no 4T20","og_description":"A Hypera Pharma (HYPE3) apresentou um lucro l\u00edquido de R$ 314,9 milh\u00f5es, crescimento de 31,9%. Clique para saber mais","og_url":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-tem-lucro-de-r-3149-mi-no-4t20\/","og_site_name":"Suno Not\u00edcias","article_publisher":"https:\/\/facebook.com\/sunoresearch","og_image":[{"width":960,"height":636,"url":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/02\/74816746-definido-fator-de-reajuste-de-precos-de-medicamentos-para-2021-3.29.jpg","type":"image\/jpeg"}],"author":"Arthur Guimar\u00e3es","twitter_card":"summary_large_image","twitter_creator":"@sunoresearch","twitter_site":"@sunoresearch","twitter_misc":{"Escrito por":"Arthur Guimar\u00e3es","Est. tempo de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-tem-lucro-de-r-3149-mi-no-4t20\/#article","isPartOf":{"@id":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-tem-lucro-de-r-3149-mi-no-4t20\/"},"author":{"name":"Arthur Guimar\u00e3es","@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/053a750a709a263919a20f976caae91c"},"headline":"Hypera Pharma (HYPE3) tem lucro de R$ 314,9 mi no 4T20","datePublished":"2021-02-26T22:18:23+00:00","dateModified":"2021-02-26T22:50:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-tem-lucro-de-r-3149-mi-no-4t20\/"},"wordCount":415,"publisher":{"@id":"https:\/\/www.suno.com.br\/noticias\/#organization"},"image":{"@id":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-tem-lucro-de-r-3149-mi-no-4t20\/#primaryimage"},"thumbnailUrl":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/02\/74816746-definido-fator-de-reajuste-de-precos-de-medicamentos-para-2021-3.29-jpg.webp","keywords":["balan\u00e7os trimestrais","Hypera Pharma (HYPE3)"],"articleSection":["Neg\u00f3cios"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-tem-lucro-de-r-3149-mi-no-4t20\/","url":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-tem-lucro-de-r-3149-mi-no-4t20\/","name":"Hypera Pharma (HYPE3) tem lucro de R$ 314,9 mi no 4T20","isPartOf":{"@id":"https:\/\/www.suno.com.br\/noticias\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-tem-lucro-de-r-3149-mi-no-4t20\/#primaryimage"},"image":{"@id":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-tem-lucro-de-r-3149-mi-no-4t20\/#primaryimage"},"thumbnailUrl":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/02\/74816746-definido-fator-de-reajuste-de-precos-de-medicamentos-para-2021-3.29-jpg.webp","datePublished":"2021-02-26T22:18:23+00:00","dateModified":"2021-02-26T22:50:22+00:00","description":"A Hypera Pharma (HYPE3) apresentou um lucro l\u00edquido de R$ 314,9 milh\u00f5es, crescimento de 31,9%. Clique para saber mais","breadcrumb":{"@id":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-tem-lucro-de-r-3149-mi-no-4t20\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-tem-lucro-de-r-3149-mi-no-4t20\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-tem-lucro-de-r-3149-mi-no-4t20\/#primaryimage","url":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/02\/74816746-definido-fator-de-reajuste-de-precos-de-medicamentos-para-2021-3.29-jpg.webp","contentUrl":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/02\/74816746-definido-fator-de-reajuste-de-precos-de-medicamentos-para-2021-3.29-jpg.webp","width":960,"height":636,"caption":"A Hypera Pharma divulgou seus resultados do 4\u00ba trimestre de 2020 nesta sexta-feira"},{"@type":"BreadcrumbList","@id":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-tem-lucro-de-r-3149-mi-no-4t20\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Not\u00edcias","item":"https:\/\/www.suno.com.br\/noticias\/"},{"@type":"ListItem","position":2,"name":"Neg\u00f3cios","item":"https:\/\/www.suno.com.br\/noticias\/negocios\/"},{"@type":"ListItem","position":3,"name":"Hypera Pharma (HYPE3) tem lucro de R$ 314,9 mi no 4T20"}]},{"@type":"WebSite","@id":"https:\/\/www.suno.com.br\/noticias\/#website","url":"https:\/\/www.suno.com.br\/noticias\/","name":"Suno Not\u00edcias","description":"Seu portal de informa\u00e7\u00e3o sobre o mundo dos investimentos","publisher":{"@id":"https:\/\/www.suno.com.br\/noticias\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.suno.com.br\/noticias\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/www.suno.com.br\/noticias\/#organization","name":"Suno Not\u00edcias","url":"https:\/\/www.suno.com.br\/noticias\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/logo\/image\/","url":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/09\/suno-logo.png","contentUrl":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/09\/suno-logo.png","width":180,"height":180,"caption":"Suno Not\u00edcias"},"image":{"@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/facebook.com\/sunoresearch","https:\/\/x.com\/sunoresearch","https:\/\/www.instagram.com\/suno","https:\/\/www.linkedin.com\/company\/suno-research\/","https:\/\/www.youtube.com\/c\/sunoresearch"]},{"@type":"Person","@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/053a750a709a263919a20f976caae91c","name":"Arthur Guimar\u00e3es","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1affd86a11209ae09eb6dd3bcad3e96c?s=96&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1affd86a11209ae09eb6dd3bcad3e96c?s=96&r=g","caption":"Arthur Guimar\u00e3es"},"description":"Arthur Guimar\u00e3es escreve sobre pol\u00edtica, economia e neg\u00f3cios para o portal de not\u00edcias da Suno Research. Atualmente, \u00e9 estudante de jornalismo pela Faculdade C\u00e1sper L\u00edbero.","url":"https:\/\/www.suno.com.br\/noticias\/author\/arthur-guimaraes\/"}]}},"default_loop_html":"<div class=\"cardsPage__listCard__boxs\"><div class=\"cardsPage__listCard__boxs__img\"><a href=\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-tem-lucro-de-r-3149-mi-no-4t20\/\"><img class=\"mask\" src=\"https:\/\/www.suno.com.br\/noticias\/wp-content\/themes\/suno\/resources\/images\/spotlight\/spotlight1img\/bg-mask.png\" alt=\"Image Mask\"\/><img src=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/02\/74816746-definido-fator-de-reajuste-de-precos-de-medicamentos-para-2021-3.29-400x200.webp\" alt=\"Hypera Pharma (HYPE3) tem lucro de R$ 314,9 mi no 4T20\"\/><\/a><span class=\"spotlightCategory\"><a href=\"https:\/\/www.suno.com.br\/noticias\/negocios\/\">Neg\u00f3cios<\/a><\/span><\/div><div class=\"cardsPage__listCard__boxs__content\"><a href=\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-tem-lucro-de-r-3149-mi-no-4t20\/\"><h2 class=\"content__title\">Hypera Pharma (HYPE3) tem lucro de R$ 314,9 mi no 4T20<\/h2><\/a><div class=\"newsContent__article__meta\"><div class=\"newsContent__article__meta__authorBox\"><a href=\"https:\/\/www.suno.com.br\/noticias\/author\/arthur-guimaraes\/\" class=\"authorBox__avatar noMobi\"><img src=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2020\/02\/dfb40897-eu-150x150.webp\" alt=\"Arthur Guimar\u00e3es\"><\/a><div class=\"authorBox__name\"><span>por\n\t\t\t<a href=\"https:\/\/www.suno.com.br\/noticias\/author\/arthur-guimaraes\/\"><span itemprop=\"author\">Arthur Guimar\u00e3es<\/span><\/a><\/span><time datetime=\"2021-02-26T19:18:23-03:00\" itemprop=\"datePublished\">26\/02\/2021 19:18<\/time><\/div><\/div><\/div><\/div><\/div>","single_layout":"posts","amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/posts\/127200"}],"collection":[{"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/comments?post=127200"}],"version-history":[{"count":7,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/posts\/127200\/revisions"}],"predecessor-version":[{"id":127318,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/posts\/127200\/revisions\/127318"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/media\/127205"}],"wp:attachment":[{"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/media?parent=127200"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/categories?post=127200"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/tags?post=127200"},{"taxonomy":"suno_strategy","embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/suno_strategy?post=127200"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}